Literature DB >> 28108498

mGluR2 versus mGluR3 Metabotropic Glutamate Receptors in Primate Dorsolateral Prefrontal Cortex: Postsynaptic mGluR3 Strengthen Working Memory Networks.

Lu E Jin1, Min Wang1, Veronica C Galvin1, Taber C Lightbourne1, Peter Jeffrey Conn2, Amy F T Arnsten1, Constantinos D Paspalas1.   

Abstract

The newly evolved circuits in layer III of primate dorsolateral prefrontal cortex (dlPFC) generate the neural representations that subserve working memory. These circuits are weakened by increased cAMP-K+ channel signaling, and are a focus of pathology in schizophrenia, aging, and Alzheimer's disease. Cognitive deficits in these disorders are increasingly associated with insults to mGluR3 metabotropic glutamate receptors, while reductions in mGluR2 appear protective. This has been perplexing, as mGluR3 has been considered glial receptors, and mGluR2 and mGluR3 have been thought to have similar functions, reducing glutamate transmission. We have discovered that, in addition to their astrocytic expression, mGluR3 is concentrated postsynaptically in spine synapses of layer III dlPFC, positioned to strengthen connectivity by inhibiting postsynaptic cAMP-K+ channel actions. In contrast, mGluR2 is principally presynaptic as expected, with only a minor postsynaptic component. Functionally, increase in the endogenous mGluR3 agonist, N-acetylaspartylglutamate, markedly enhanced dlPFC Delay cell firing during a working memory task via inhibition of cAMP signaling, while the mGluR2 positive allosteric modulator, BINA, produced an inverted-U dose-response on dlPFC Delay cell firing and working memory performance. These data illuminate why insults to mGluR3 would erode cognitive abilities, and support mGluR3 as a novel therapeutic target for higher cognitive disorders.
© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer's disease; GRM2; GRM3; dendritic spine; schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 28108498      PMCID: PMC5974790          DOI: 10.1093/cercor/bhx005

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  45 in total

1.  Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

Authors:  Michael F Egan; Richard E Straub; Terry E Goldberg; Imtiaz Yakub; Joseph H Callicott; Ahmad R Hariri; Venkata S Mattay; Alessandro Bertolino; Thomas M Hyde; Cynthia Shannon-Weickert; Mayada Akil; Jeremy Crook; Radha Krishna Vakkalanka; Rishi Balkissoon; Richard A Gibbs; Joel E Kleinman; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

2.  Mice lacking glutamate carboxypeptidase II develop normally, but are less susceptible to traumatic brain injury.

Authors:  Yang Gao; Siyi Xu; Zhenwen Cui; Mingkun Zhang; Yingying Lin; Lei Cai; Zhugang Wang; Xingguang Luo; Yan Zheng; Yong Wang; Qizhong Luo; Jiyao Jiang; Joseph H Neale; Chunlong Zhong
Journal:  J Neurochem       Date:  2015-04-28       Impact factor: 5.372

3.  The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.

Authors:  Corrado Corti; Giuseppe Battaglia; Gemma Molinaro; Barbara Riozzi; Anna Pittaluga; Mauro Corsi; Manolo Mugnaini; Ferdinando Nicoletti; Valeria Bruno
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

4.  Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia.

Authors:  W M Perlstein; C S Carter; D C Noll; J D Cohen
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 5.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

6.  Evaluation of relationship between GRM3 polymorphisms and cognitive function in schizophrenia of Han Chinese.

Authors:  Ming Chang; Linyan Sun; Xinmei Liu; Wei Sun; Ming Ji; Zhenhong Wang; Yonghui Wang; Xuqun You
Journal:  Psychiatry Res       Date:  2015-06-25       Impact factor: 3.222

7.  Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.

Authors:  Filippo Caraci; Gemma Molinaro; Giuseppe Battaglia; Maria Laura Giuffrida; Barbara Riozzi; Anna Traficante; Valeria Bruno; Milena Cannella; Sara Merlo; Xushan Wang; Beverly A Heinz; Eric S Nisenbaum; Thomas C Britton; Filippo Drago; Maria Angela Sortino; Agata Copani; Ferdinando Nicoletti
Journal:  Mol Pharmacol       Date:  2010-12-15       Impact factor: 4.436

8.  Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.

Authors:  Jeffrey R Bishop; James L Reilly; Margret S H Harris; Shitalben R Patel; Rick Kittles; Judith A Badner; Konasale M Prasad; Vishwajit L Nimgaonkar; Matcheri S Keshavan; John A Sweeney
Journal:  Psychopharmacology (Berl)       Date:  2014-08-07       Impact factor: 4.530

9.  A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis.

Authors:  Michael A Benneyworth; Zixiu Xiang; Randy L Smith; Efrain E Garcia; P Jeffrey Conn; Elaine Sanders-Bush
Journal:  Mol Pharmacol       Date:  2007-05-25       Impact factor: 4.436

10.  mGluR2/3 mechanisms in primate dorsolateral prefrontal cortex: evidence for both presynaptic and postsynaptic actions.

Authors:  L E Jin; M Wang; S-T Yang; Y Yang; V C Galvin; T C Lightbourne; D Ottenheimer; Q Zhong; J Stein; A Raja; C D Paspalas; A F T Arnsten
Journal:  Mol Psychiatry       Date:  2016-08-09       Impact factor: 15.992

View more
  30 in total

Review 1.  Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.

Authors:  Andreas Reiner; Joshua Levitz
Journal:  Neuron       Date:  2018-06-27       Impact factor: 17.173

2.  Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.

Authors:  Bo Xing; Genie Han; Min-Juan Wang; Melissa A Snyder; Wen-Jun Gao
Journal:  Neuropharmacology       Date:  2018-05-14       Impact factor: 5.250

3.  Metabotropic Glutamate Receptors in Alcohol Use Disorder: Physiology, Plasticity, and Promising Pharmacotherapies.

Authors:  Max E Joffe; Samuel W Centanni; Anel A Jaramillo; Danny G Winder; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2018-06-08       Impact factor: 4.418

Review 4.  A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition.

Authors:  Joseph H Neale; Rafal Olszewski
Journal:  Neurobiol Learn Mem       Date:  2019-01-07       Impact factor: 2.877

5.  Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress.

Authors:  Max E Joffe; Chiaki I Santiago; Branden J Stansley; James Maksymetz; Rocco G Gogliotti; Julie L Engers; Ferdinando Nicoletti; Craig W Lindsley; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2018-10-13       Impact factor: 5.250

Review 6.  Neuropharmacological Insight from Allosteric Modulation of mGlu Receptors.

Authors:  Branden J Stansley; P Jeffrey Conn
Journal:  Trends Pharmacol Sci       Date:  2019-02-26       Impact factor: 14.819

7.  mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects.

Authors:  Max E Joffe; Chiaki I Santiago; Kendra H Oliver; James Maksymetz; Nicholas A Harris; Julie L Engers; Craig W Lindsley; Danny G Winder; P Jeffrey Conn
Journal:  Neuron       Date:  2019-11-14       Impact factor: 17.173

8.  Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.

Authors:  Luisa Di Menna; Max E Joffe; Luisa Iacovelli; Rosamaria Orlando; Craig W Lindsley; Jèrome Mairesse; Pierre Gressèns; Milena Cannella; Filippo Caraci; Agata Copani; Valeria Bruno; Giuseppe Battaglia; P Jeffrey Conn; Ferdinando Nicoletti
Journal:  Neuropharmacology       Date:  2017-10-25       Impact factor: 5.250

9.  Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia.

Authors:  Dibyadeep Datta; Amy F T Arnsten
Journal:  ACS Chem Neurosci       Date:  2018-03-01       Impact factor: 4.418

10.  Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors.

Authors:  Max E Joffe; Chiaki I Santiago; Sheryl Anne D Vermudez; Nicole M Fisher; Shalini Dogra; Colleen M Niswender; P Jeffrey Conn
Journal:  Neuropsychopharmacology       Date:  2021-05-25       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.